Can limonene be a possible candidate for evaluation as an agent or adjuvant against infection, immunity, and inflammation in COVID-19?
Mohamed Fizur Nagoor Meeran, A. Seenipandi, Hayate Javed, Charu Sharma, Hebaallah Mamdouh Hashiesh, Sameer N. Goyal, Niraj Kumar Jha, Shreesh Ojha
Abstract
effects confirmed in the experimental studies and further proof of the concept studies. The candidature of LMN in COVID-19 treatment somewhat appear speculative but cannot be overlooked provided favorable physiochemical and druggable properties. The safety and efficacy of LMN are necessary to be established in preclinical and clinical studies before making suggestions for use in humans.
Topics & Concepts
InflammationImmune systemImmunologyCoronavirusImmunityAdjuvantDiseaseMedicineCoronavirus disease 2019 (COVID-19)BiologyInfectious disease (medical specialty)Internal medicinePiperaceae Chemical and Biological StudiesEssential Oils and Antimicrobial ActivityMedicinal Plant Research